🔎 Trials Near Me

Dachaigh › Ailse Endometrial › Texas › Austin

Sgrùdaidhean clionaigeach Ailse Endometrial ann an Austin, TX

Tha 15 sgrùdaidhean airson Ailse Endometrial a’ lorg phàirtichean aig làraichean ann agus timcheall air Austin (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

A’ fastadhÌre 1/2
  • New Experimental Therapeutics - NEXT Oncology, Austin
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT04585750

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

A’ fastadhÌre 1
  • NEXT Austin, Austin
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06270706

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

A’ fastadhÌre 1
  • NEXT Oncology, Austin
Aoisean 19 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06586957

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

A’ fastadhÌre 3
  • USOR - Texas Oncology, Austin
  • USOR - Texas Oncology, Austin
  • USOR - Texas Oncology- Austin North, Austin
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 9 Sult 2026 · NCT07166094

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

A’ fastadhÌre 1
  • NEXT Austin, Austin
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Lùna 2026 · NCT07227168

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

A’ fastadhÌre 1
  • NEXT Austin, Austin
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT07383506

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

A’ fastadhÌre 1
  • NEXT Oncology - Austin, Austin
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Lùna 2026 · NCT07444814

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

A’ fastadhÌre 1/2
  • Texas Oncology - Central / South Texas, Austin
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT05579366

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

A’ fastadhÌre 1/2
  • Texas Oncology - Central/South Texas, Austin
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

A’ fastadhÌre 3
  • Research Site, Austin
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 29 Iuch 2026 · NCT07044336

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

A’ fastadhÌre 1
  • NEXT Texas LLC - Austin, Austin
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Ògmh 2026 · NCT07503808

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • Elligo Health Research, Inc., Austin
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 20 Faoi 2026 · NCT05366881

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

A’ fastadhÌre 1
  • Dren Investigational Site, Austin
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Faoi 2026 · NCT06999187

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

A’ fastadhÌre 2/3
  • Texas Oncology-Austin Central, Austin
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 2 Cèit 2024 · NCT05797831

Sgrùdaidhean Ailse Endometrial ann am bailtean eile

Sgrùdaidhean eile ann an Austin

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.